How Close are We to a COVID-19 Vaccine?

dc.authoridOzkan, Kayhan/0000-0002-5956-093X
dc.authorwosidOzkan, Kayhan/AAP-7351-2020
dc.contributor.authorOzkan, Kayhan
dc.date.accessioned2021-12-01T18:47:19Z
dc.date.available2021-12-01T18:47:19Z
dc.date.issued2020
dc.department[Belirlenecek]en_US
dc.description.abstractThis review provides an overview regarding the main aspects of candidate COVID-19 vaccines and pathophysiology of disease. The types of biotechnological candidate vaccines to be developed against COVID-19, their degree of protection and the pathophysiological mechanism of the disease were analyzed in this review article. The literature data on which cruxes for the development of biotechnological candidate vaccines to be wended are based was researched. Data that could give reference to various biotechnological candidate vaccines were reviewed. For this purpose, up-to-date literature data was utilized. The ways to succeed in the development of a vaccine requiring a technological infrastructure are to synthesize the data obtained from long term trials and to put them into practice subsequently. The vaccines to be developed by means of recombinant DNA technology will be a source of inspiration to people for further studies. After a rapid process of vaccine development, the use of COVID-19 vaccine can be mainstreamed among people to prevent the disease. As a result of these practices, the evaluation of which vaccine will be more safe, reliable and effective will be performed after phase studies.en_US
dc.identifier.doi10.22207/JPAM.14.SPL1.26
dc.identifier.endpage902en_US
dc.identifier.issn0973-7510
dc.identifier.issn2581-690X
dc.identifier.scopus2-s2.0-85086991613en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage893en_US
dc.identifier.urihttps://doi.org/10.22207/JPAM.14.SPL1.26
dc.identifier.urihttps://hdl.handle.net/20.500.12684/10227
dc.identifier.volume14en_US
dc.identifier.wosWOS:000538476900026en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.institutionauthorOzkan, Kayhan
dc.language.isoenen_US
dc.publisherDr M N Khanen_US
dc.relation.ispartofJournal Of Pure And Applied Microbiologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCOVID-19 vaccineen_US
dc.subjectrecombinanten_US
dc.subjectatteneu virusen_US
dc.subjectimmune responseen_US
dc.subjectphase studiesen_US
dc.subjectCoronavirus Vaccineen_US
dc.subjectPseudorabies Virusen_US
dc.subjectProtectionen_US
dc.subjectDiseaseen_US
dc.subjectTransporten_US
dc.subjectChickensen_US
dc.subjectImmunityen_US
dc.subjectChinaen_US
dc.subjectWuhanen_US
dc.titleHow Close are We to a COVID-19 Vaccine?en_US
dc.typeReview Articleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
10226.pdf
Boyut:
309.26 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text